0.96
price up icon1.05%   0.01
 
loading
Schlusskurs vom Vortag:
$0.95
Offen:
$0.9
24-Stunden-Volumen:
36,746
Relative Volume:
0.23
Marktkapitalisierung:
$8.97M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-13.51%
1M Leistung:
-41.46%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$0.90
$1.0505
1-Wochen-Bereich:
Value
$0.90
$1.11
52-Wochen-Spanne:
Value
$0.90
$5.50

Gelteq Ltd Stock (GELS) Company Profile

Name
Firmenname
Gelteq Ltd
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
8
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
GELS's Discussions on Twitter

Vergleichen Sie GELS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
GELS
Gelteq Ltd
0.96 8.97M 0 0 0 0.00
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
163.26 72.50B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.96 47.08B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.15 45.99B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
15.32 17.38B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
ITCI
Intra Cellular Therapies Inc
131.87 14.05B 612.78M -86.37M -62.91M -0.87

Gelteq Ltd Aktie (GELS) Neueste Nachrichten

pulisher
Mar 28, 2025

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Mar 28, 2025
pulisher
Mar 24, 2025

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Mar 24, 2025
pulisher
Mar 21, 2025

CNS Pharma Stock Price, Quotes and Forecasts | NASDAQ:CNSP - Benzinga

Mar 21, 2025
pulisher
Mar 21, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Mar 21, 2025
pulisher
Mar 07, 2025

Athira Pharma Stock Price, Quotes and Forecasts | NASDAQ:ATHA - Benzinga

Mar 07, 2025
pulisher
Mar 03, 2025

Addex Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ADXN - Benzinga

Mar 03, 2025
pulisher
Feb 04, 2025

Gelteq introduces SportsGel with China deal in H1 2025 - Investing.com India

Feb 04, 2025
pulisher
Feb 04, 2025

Gelteq introduces SportsGel with China deal in H1 2025 By Investing.com - Investing.com South Africa

Feb 04, 2025
pulisher
Jan 28, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Jan 28, 2025
pulisher
Jan 24, 2025

Gelteq Appoints Matthew Jones as Head of Sports Performance - GlobeNewswire Inc.

Jan 24, 2025
pulisher
Jan 24, 2025

Gelteq Taps UAE Football, Boston Celtics Nutrition Expert to Lead Sports Performance Division - StockTitan

Jan 24, 2025
pulisher
Jan 22, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Jan 22, 2025
pulisher
Dec 19, 2024

Gelteq Strengthens Leadership with Renowned Scientist Dr. Paul Wynne as Chief Scientific Officer - StockTitan

Dec 19, 2024
pulisher
Dec 18, 2024

“Gelteq has been continuously evolving to expand applications and audiences” - AlphaStreet

Dec 18, 2024
pulisher
Dec 17, 2024

Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug - The Manila Times

Dec 17, 2024
pulisher
Dec 10, 2024

Why C3.ai Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga

Dec 10, 2024
pulisher
Dec 09, 2024

Gelteq CEO to Present at Benchmark's Discovery Investor Conference - StockTitan

Dec 09, 2024
pulisher
Dec 04, 2024

The Benchmark Company Announces Upcoming Discovery One-on-One Investor Conference - The Manila Times

Dec 04, 2024
pulisher
Dec 03, 2024

Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket - Inkl

Dec 03, 2024
pulisher
Dec 02, 2024

Oral drug and nutrient gel specialist soars after top client bumps up order by 50% - Mugglehead

Dec 02, 2024
pulisher
Dec 02, 2024

NovoCure Limited (NASDAQ: NVCR): Groundbreaking PANOVA-3 Trial Results Signal Hope for Pancreatic Cancer Patients - BP Journal

Dec 02, 2024
pulisher
Dec 02, 2024

Gelteq Limited (NASDAQ: GELS): Transforming Nutraceuticals with Gel-Based Innovation and Strategic U.S. Expansion - BP Journal

Dec 02, 2024
pulisher
Dec 02, 2024

The Ascending Trajectory of Purple Biotech Ltd (PPBT): Pioneering Pancreatic Cancer Treatment with CM24 - BP Journal

Dec 02, 2024
pulisher
Dec 02, 2024

Senti Biosciences, Inc. (SNTI) could keep surging and here’s why - BP Journal

Dec 02, 2024
pulisher
Dec 02, 2024

Stock market news: Senti Biosciences +404.62%, Fossil Group +54.11% among top gainers during mid day trading - Business Upturn

Dec 02, 2024
pulisher
Dec 02, 2024

Polyrizon Ltd.’s Quiet Period To End on December 9th (NASDAQ:PLRZ) - Defense World

Dec 02, 2024
pulisher
Dec 02, 2024

Gelteq Limited’s (NASDAQ:GELS) Quiet Period To End on December 9th - Defense World

Dec 02, 2024
pulisher
Nov 26, 2024

Gelteq (GELS) Ramps Up Production: 400,000 Gel Units Set for Global Distribution | GELS Stock News - StockTitan

Nov 26, 2024
pulisher
Nov 17, 2024

Ins & OutsWeek Ending 11/15/2024 - substack.com

Nov 17, 2024
pulisher
Nov 14, 2024

Gelteq Limited Appoints Adam Bendell as President of U.S. Operations - Marketscreener.com

Nov 14, 2024
pulisher
Nov 12, 2024

Gelteq (GELS) Accelerates U.S. Growth, Appoints Former Deloitte Executive as President - StockTitan

Nov 12, 2024
pulisher
Nov 08, 2024

Med-tech funding rises, driven by private investments and follow-ons - BioWorld Online

Nov 08, 2024
pulisher
Oct 31, 2024

Gelteq Closes $5.2M IPO By Investing.com - Investing.com Australia

Oct 31, 2024
pulisher
Oct 30, 2024

Gelteq launches IPO, raises $5.2 million for expansion - Investing.com India

Oct 30, 2024
pulisher
Oct 30, 2024

Gelteq Limited Closes US$5.2 Million Initial Public Offering - The Manila Times

Oct 30, 2024
pulisher
Oct 30, 2024

GELSGelteq Limited Ordinary Shares Latest Stock News & Market Updates - StockTitan

Oct 30, 2024
pulisher
Oct 29, 2024

Argent Biopharma Lists New Shares on ASX - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

Biotech company Gelteq prices IPO at $4 per share - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

Vietnam Manufacturing & Export Processing to Announce Quarterly Results - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

Maas Group Reports Record Results and Growth Strategy - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

Qualitas Limited Releases 2024 Governance Statement - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

Biotech company Gelteq prices IPO at $4 per share (NASDAQ:GELS) - Seeking Alpha

Oct 29, 2024
pulisher
Oct 28, 2024

WiseTech Investor Urges Progress, Transparency Amid CEO Scandal - MSN

Oct 28, 2024
pulisher
Oct 28, 2024

Novatti Group Announces Hybrid Annual General Meeting - MSN

Oct 28, 2024
pulisher
Oct 28, 2024

Gelteq Limited Prices US$5.2 Million Initial Public Offering - The Manila Times

Oct 28, 2024
pulisher
Oct 28, 2024

RooLife Group Announces AGM with Key Resolutions - MSN

Oct 28, 2024
pulisher
Oct 25, 2024

Ingram Micro IPO: Major tech product distributor debuts on NYSE today after pricing its stock within target range - MSN

Oct 25, 2024
pulisher
Oct 24, 2024

Strike Resources Limited Announces Upcoming AGM Details - MSN

Oct 24, 2024
pulisher
Oct 21, 2024

IPO Roundup: Ingram Micro Holdings, Peak Resources and more (NYSEARCA:IPO) - Seeking Alpha

Oct 21, 2024
pulisher
Oct 03, 2024

Nathan Givoni & Simon Szewach on Gelteq - The Good Men Project

Oct 03, 2024
pulisher
Oct 01, 2024

Aldebaran Financial Inc. Purchases 710 Shares of Invesco QQQ (NASDAQ:QQQ) - Defense World

Oct 01, 2024

Finanzdaten der Gelteq Ltd-Aktie (GELS)

Es liegen keine Finanzdaten für Gelteq Ltd (GELS) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$32.55
price up icon 0.09%
$97.31
price down icon 0.50%
$8.575
price down icon 0.29%
$107.56
price up icon 0.54%
$312.09
price up icon 1.70%
$131.87
price down icon 0.04%
Kapitalisierung:     |  Volumen (24h):